Tissue Regenix Group (LSE:TRX) FCF Yield % : 0.32 (As of May. 22, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Tissue Regenix Group's Trailing 12-Month Free Cash Flow is £0.14 Mil, and Market Cap is £43.76 Mil. Therefore, Tissue Regenix Group's FCF Yield % for today is 0.32%.

The historical rank and industry rank for Tissue Regenix Group's FCF Yield % or its related term are showing as below:

LSE:TRX' s FCF Yield % Range Over the Past 10 Years
Min: -201.96 Med: -8.96 Max: 0.39
Current: 0.32

During the past 13 years, the highest FCF Yield % of Tissue Regenix Group was 0.39%. The lowest was -201.96%. And the median was -8.96%.

LSE:TRX's FCF Yield % is ranked better than
86.95% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs LSE:TRX: 0.32

Tissue Regenix Group's FCF Margin % for the quarter that ended in Dec. 2023 was 8.57%.

Tissue Regenix Group FCF Yield % Historical Data

The historical data trend for Tissue Regenix Group's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group FCF Yield % Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-62.60

-15.52

-10.04

-4.92

0.38

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-4.70	-6.87	-4.31	-5.03	5.68

Competitive Comparison of Tissue Regenix Group's FCF Yield %

For the Biotechnology subindustry, Tissue Regenix Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's FCF Yield % falls into.

Tissue Regenix Group FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Tissue Regenix Group's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	0.14	/	36.69874
	=	0.38%

Tissue Regenix Group's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	1.042	*	2	/	36.69874
	=	5.68%

Tissue Regenix Group FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Tissue Regenix Group FCF Yield % Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.